Profile data is unavailable for this security.
About the company
Gamida Cell Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company develops cell therapies that are designed to cure cancer and rare, serious hematologic diseases. The Company is leveraging its nicotinamide (NAM)-based cell expansion technology toto expand multiple cell types including stem cells and natural killer (NK) cells while maintaining their original phenotype and potency. The following are the Company's clinical pipeline products: Omidubicel dedicated to hematologic malignancies and severe aplastic anemia; GDA-201 dedicated for treatment of non-Hodgkin Lymphoma; GDA-301, GDA-401, GDA-501 dedicated to treatment of solid tumors, GDA-601 dedicated to multiple myeloma.
- Revenue in USD (TTM)673.00k
- Net income in USD-76.95m
- Incorporated1998
- Employees143.00
- LocationGamida Cell LtdPO Box 34670JERUSALEM 91340IsraelISR
- Phone+972 26595666
- Fax+972 26595616
- Websitehttps://www.gamida-cell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eiger Biopharmaceuticals Inc | 14.67m | -86.65m | 7.37m | 51.00 | -- | -- | -- | 0.5024 | -1.96 | -1.96 | 0.3317 | -0.0361 | 0.1471 | 0.1316 | 7.76 | 261,892.90 | -86.91 | -56.95 | -110.55 | -67.83 | 98.24 | -- | -590.80 | -1,242.44 | 3.24 | -28.50 | 1.04 | -- | 11.05 | -- | -185.33 | -- | 50.52 | -- |
Enveric Biosciences Inc | 0.00 | -17.46m | 7.44m | 7.00 | -- | 1.43 | -- | -- | -8.15 | -8.15 | 0.00 | 0.7142 | 0.00 | -- | -- | 0.00 | -144.99 | -104.94 | -207.98 | -156.88 | -- | -- | -- | -243.54 | -- | -- | 0.00 | -- | -- | -- | 7.14 | -- | -- | -- |
Pasithea Therapeutics Corp | 240.71k | -15.59m | 7.45m | 15.00 | -- | 0.2625 | -- | 30.95 | -12.41 | -12.75 | 0.191 | 27.23 | 0.006 | -- | -- | 16,047.33 | -38.86 | -- | -40.66 | -- | 100.54 | -- | -6,478.41 | -- | -- | -- | 0.00 | -- | 3,130.81 | -- | -541.19 | -- | -- | -- |
Manuka Inc | 671.00k | -1.14m | 7.56m | 4.00 | -- | -- | -- | 11.27 | -0.0128 | -0.0128 | 0.0066 | -0.0124 | 2.41 | 0.9412 | 37.28 | 167,750.00 | -410.43 | -463.75 | -- | -- | 88.08 | -- | -170.04 | -732.15 | 0.0194 | -- | -- | -- | -- | -- | -854.23 | -- | -- | -- |
Aquabounty Technologies Inc | 2.37m | -25.20m | 7.66m | 100.00 | -- | 0.0442 | -- | 3.23 | -6.95 | -6.95 | 0.6526 | 45.02 | 0.0114 | 7.43 | -- | 23,703.50 | -12.14 | -15.91 | -13.03 | -16.53 | -534.21 | -637.66 | -1,063.23 | -1,793.57 | 1.80 | -94.87 | 0.0469 | -- | 167.01 | 125.94 | 0.7409 | -- | 28.79 | -- |
First Wave BioPharma Inc | 0.00 | -15.91m | 7.80m | 10.00 | -- | 0.811 | -- | -- | -194.33 | -194.33 | 0.00 | 4.87 | 0.00 | -- | -- | 0.00 | -296.61 | -289.07 | -2,246.39 | -1,505.45 | -- | -- | -- | -- | -- | -955.30 | 0.00 | -- | -- | -- | 82.28 | -- | -- | -- |
Longeveron Inc | 709.00k | -22.21m | 7.82m | 23.00 | -- | 7.33 | -- | 11.03 | -10.18 | -10.18 | 0.3262 | 0.4245 | 0.0359 | -- | 4.31 | 30,826.09 | -108.45 | -63.15 | -139.35 | -75.68 | 31.17 | 33.70 | -3,020.17 | -441.02 | -- | -- | 0.00 | -- | -41.98 | -19.78 | -17.92 | -- | 26.80 | -- |
Gamida Cell Ltd | 673.00k | -76.95m | 7.85m | 143.00 | -- | 20.45 | -- | 11.67 | -0.8936 | -0.8936 | 0.0071 | 0.0029 | 0.0058 | -- | -- | 4,706.29 | -66.32 | -60.47 | -81.56 | -71.29 | 6.98 | -- | -11,434.03 | -- | 3.20 | -- | 0.9953 | -- | -- | -- | 11.60 | -- | 73.69 | -- |
CeCors Inc | -100.00bn | -100.00bn | 7.87m | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
Plus Therapeutics Inc (USA) | 4.91m | -13.32m | 7.91m | 20.00 | -- | -- | -- | 1.61 | -4.51 | -4.51 | 1.57 | -0.3033 | 0.2787 | -- | -- | 245,650.00 | -75.54 | -59.18 | -210.10 | -133.04 | -- | -- | -271.04 | -470.45 | -- | -- | 1.51 | -- | 2,093.30 | -5.89 | 34.32 | -- | 3.77 | -- |
Lixte Biotechnology Holdings Inc | 0.00 | -5.09m | 7.92m | 3.00 | -- | 16.00 | -- | -- | -2.77 | -2.77 | 0.00 | 1.78 | 0.00 | -- | -- | 0.00 | -103.09 | -104.18 | -111.07 | -111.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Protagenic Therapeutics Inc | 0.00 | -3.93m | 8.07m | -- | -- | 1.90 | -- | -- | -0.9072 | -0.9072 | 0.00 | 0.9588 | 0.00 | -- | -- | -- | -57.36 | -81.23 | -66.24 | -106.78 | -- | -- | -- | -- | -- | -- | 0.0918 | -- | -- | -- | 21.39 | -- | -- | -- |
Kazia Therapeutics Ltd (ADR) | 14.74k | -13.37m | 8.27m | 12.00 | -- | 0.9086 | -- | 561.09 | -0.8109 | -0.8109 | 0.0008 | 0.3453 | 0.0007 | -- | 73.97 | -- | -63.98 | -46.35 | -82.39 | -54.75 | -- | -- | -90,714.45 | -497.17 | -- | -- | 0.1297 | -- | 979.43 | -28.31 | 18.19 | -- | -- | -- |
Cannabis Bioscience Internatnl Hlgs Inc | 56.94m | 6.94m | 8.31m | 389.00 | 0.0015 | 0.0002 | 0.9003 | 0.1459 | 0.5328 | 0.5328 | 4.29 | 4.92 | 0.5917 | 62.81 | 1.45 | 146,384.30 | 7.83 | -- | 11.73 | -- | 31.96 | -- | 13.24 | -- | 0.6856 | 50.75 | 0.0631 | -- | 12.79 | -- | 177.84 | -- | -- | -- |
Theriva Biologics Inc | 0.00 | -18.46m | 8.31m | 21.00 | -- | 0.2007 | -- | -- | -1.18 | -1.18 | 0.00 | 2.57 | 0.00 | -- | -- | 0.00 | -26.32 | -42.49 | -31.20 | -46.29 | -- | -- | -- | -- | -- | -- | 0.0049 | -- | -- | -- | 13.64 | -- | -11.36 | -- |
Holder | Shares | % Held |
---|---|---|
Levin Capital Strategies LPas of 08 Feb 2024 | 9.13m | 6.88% |
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 7.61m | 5.74% |
Meitav Mutual Funds Ltd.as of 31 Dec 2023 | 3.66m | 2.76% |
Millennium Management LLCas of 31 Dec 2023 | 2.57m | 1.94% |
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Ltd.as of 31 Dec 2023 | 2.21m | 1.67% |
ARK Investment Management LLCas of 31 Dec 2023 | 2.14m | 1.62% |
Mariner LLCas of 31 Dec 2023 | 1.02m | 0.77% |
Renaissance Technologies LLCas of 31 Dec 2023 | 957.58k | 0.72% |
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet Ltd.as of 31 Dec 2023 | 801.84k | 0.61% |
Nantahala Capital Management LLCas of 31 Dec 2023 | 800.00k | 0.60% |